EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation

Guang Yan, Tianhang Zhu, Jiawei Zhou, Xia Li, Zonghua Wen, Bahaerguli Miuhuitijiang, Zhiyong Zhang, Yuejun Du, Chengyao Li, Xiaojun Shi, Wanlong Tan iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Guang Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Receptors, Androgen, Transcriptional Activation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Supported by Pudong Institute of Clinical Chinese Medicine, The "Fourteenth Five-Year Plan" Traditional Chinese Medicine Specialty Project for the Construction of Andrology Departments in TCM, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant transcriptional activation of the androgen receptor (AR) is a predominant cause of prostate cancer (PCa), including both in the initial and androgen‐independent stages. Our study highlights Golgi membrane protein 1 (GOLM1) as a key regulator of AR‐driven transcriptional activity in PCa progression. Utilizing local clinical data and TCGA data, we have established a robust association between GOLM1 and AR target genes, and further demonstrated that GOLM1 can enhance the expression of AR target genes. We discovered that GOLM1 interacts with PSMD1, a component of the 19S regulatory complex in the 26S proteasome, using mass spectrometry and Co‐IP analysis. It is well known that ubiquitin‐proteasome plays a vital role in AR expression and transcriptional regulation. Our findings demonstrate that GOLM1 enhances ubiquitin proteasome activity by binding to PSMD1, thereby facilitating AR‐driven transcriptional activity and PCa progression. These results indicate that GOLM1 and its associated proteins may become potential therapeutic targets for PCa characterized by dysregulated AR‐driven transcriptional activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsReceptors, AndrogenTranscriptional ActivationGene Expression Regulation, NeoplasticMembrane ProteinsDisease ProgressionProteasome Endopeptidase ComplexHumansMaleCell Line, TumorProtein BindingAnimalsMice

Stichwörter der Autor:innen

ARGOLM1PSMD1UPSprostate cancer

Substanzen

Receptors, AndrogenMembrane ProteinsProteasome Endopeptidase ComplexGOLM1 protein, humanAR protein, human

Autor:innen und Institutionen

  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Andrology, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Department of Pathology, Shenzhen University General Hospital, Shenzhen, China.
  • Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.

ORCID-Profile: Wanlong Tan

Förderung

  • Supported by Pudong Institute of Clinical Chinese Medicine
  • The "Fourteenth Five-Year Plan" Traditional Chinese Medicine Specialty Project for the Construction of Andrology Departments in TCM
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Yan, G., Zhu, T., Zhou, J., Li, X., Wen, Z., Miuhuitijiang, B., Zhang, Z., Du, Y., Li, C., Shi, X., & Tan, W. (2024). GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70186

Vancouver

Yan G, Zhu T, Zhou J, Li X, Wen Z, Miuhuitijiang B, et al. GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70186

BibTeX
@article{Yan2024,
  author = {Yan, Guang and Zhu, Tianhang and Zhou, Jiawei and Li, Xia and Wen, Zonghua and Miuhuitijiang, Bahaerguli and Zhang, Zhiyong and Du, Yuejun and Li, Chengyao and Shi, Xiaojun and Tan, Wanlong},
  title = {GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70186}
}
Kostenlos starten →